Agenus (AGEN) Cash & Equivalents (2010 - 2026)

Agenus' Cash & Equivalents history runs 17 years deep, the most recent figure standing at $35.0 million for Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 89.29% year-over-year to $35.0 million in Q1 2026; TTM through Mar 2026 was $35.0 million, a 89.29% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, down 92.59% from the prior year.
• Cash & Equivalents advanced to $35.0 million in Q1 2026 per AGEN's latest filing, from $3.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $247.7 million in Q1 2022 and bottomed at $3.0 million in Q4 2025.
• The 5-year median for Cash & Equivalents is $76.1 million (2023), against an average of $97.3 million.
• Across the five-year window, Cash & Equivalents soared 210.55% in 2022 and tumbled 92.59% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $178.7 million in 2022, then sank by 57.4% to $76.1 million in 2023, then plunged by 46.87% to $40.4 million in 2024, then tumbled by 92.59% to $3.0 million in 2025, then jumped by 1067.31% to $35.0 million in 2026.
• Per Business Quant, the three latest AGEN Cash & Equivalents figures stand at $35.0 million (Q1 2026), $3.0 million (Q4 2025), and $3.5 million (Q3 2025).